Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 10/2016

Open Access 01-10-2016 | Clinical Investigation

MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts

Authors: Aukje A. J. M. van Tilborg, Hester J. Scheffer, Marcus C. de Jong, Laurien G. P. H. Vroomen, Karin Nielsen, Cornelis van Kuijk, Petrousjka M. P. van den Tol, Martijn R. Meijerink

Published in: CardioVascular and Interventional Radiology | Issue 10/2016

Login to get access

Abstract

Purpose

To retrospectively analyse the safety and efficacy of radiofrequency ablation (RFA) versus microwave ablation (MWA) in the treatment of unresectable colorectal liver metastases (CRLM) in proximity to large vessels and/or major bile ducts.

Method and Materials

A database search was performed to include patients with unresectable histologically proven and/or 18F–FDG–PET avid CRLM who were treated with RFA or MWA between January 2001 and September 2014 in a single centre. All lesions that were considered to have a peribiliary and/or perivascular location were included. Univariate logistic regression analysis was performed to assess the distribution of patient, tumour and procedure characteristics. Multivariate logistic regression was used to correct for potential confounders.

Results

Two hundred and forty-three patients with 774 unresectable CRLM were ablated. One hundred and twenty-two patients (78 males; 44 females) had at least one perivascular or peribiliary lesion (n = 199). Primary efficacy rate of RFA was superior to MWA after 3 and 12 months of follow-up (P = 0.010 and P = 0.022); however, after multivariate analysis this difference was non-significant at 12 months (P = 0.078) and vanished after repeat ablations (P = 0.39). More CTCAE grade III complications occurred after MWA versus RFA (18.8 vs. 7.9 %; P = 0.094); biliary complications were especially common after peribiliary MWA (P = 0.002).

Conclusion

For perivascular CRLM, RFA and MWA are both safe treatment options that appear equally effective. For peribiliary CRLM, MWA has a higher complication rate than RFA, with similar efficacy. Based on these results, it is advised to use RFA for lesions in the proximity of major bile ducts.
Literature
1.
Steward BW, Kleihues P, editors. Colorectal Cancer World Cancer Report. Lyon: IACR Press; 2003. p. 198–202.
2.
Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235(6):759–66.CrossRefPubMedPubMedCentral
3.
Kornprat P, Jarnagin WR, Gonen M, Dematteo RP, Fong Y, Blumgart LH, et al. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol. 2007;14(3):1151–60.CrossRefPubMed
4.
Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013. Eur Radiol. 2015;25(12):3438–54.CrossRefPubMedPubMedCentral
5.
Solbiati L, Ahmed M, Cova L, Ierace T, Brioschi M, Goldberg SN. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265(3):958–68.CrossRefPubMed
6.
Van Tilborg AA, Meijerink MR, Sietses C, Van Waesberghe JH, Mackintosh MO, Meijer S, et al. Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol. 2011;84(1002):556–65.CrossRefPubMedPubMedCentral
7.
Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009;19(5):1206–13.CrossRefPubMed
8.
Simon CF, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25:S69–83.CrossRefPubMed
9.
Dupuy DE. Microwave ablation compared with radiofrequency ablation in lung tissue-is microwave not just for popcorn anymore? Radiology. 2009;251:617–8.CrossRefPubMed
10.
Boss A, Dupuy D, Pereira PL. Microwave. In: Vogl TJ, Helmberger TK, Mack MG, Reiser MF, editors. Percutaneous tumor ablation in medical radiology. 1st ed. Berlin: Springer; 2008. p. 21–8.CrossRef
11.
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.CrossRefPubMed
12.
13.
Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. International Working Group on Image-Guided Tumor Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. J Vasc Interv Radiol. 2014;25(11):1691–705.CrossRefPubMed
14.
Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33(1):11–7.CrossRefPubMed
15.
Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011;21(12):2584–96.CrossRefPubMed
16.
Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40(11):1054–60.CrossRefPubMed
17.
Signoriello S, Annunziata A, Lama N, Signoriello G, Chiodini P, De Sio I, et al. Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. Sci World J. 2012;2012:564706.CrossRef
18.
Qian GJ, Wang N, Shen Q, Sheng YH, Zhao JQ, Kuang M, et al. Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies. Eur Radiol. 2012;22(9):1983–90.CrossRefPubMed
19.
Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262(1):43–58.CrossRefPubMed
20.
Abdelaziz A, Elbaz T, Shousha HI, Mahmoud S, Ibrahim M, Abdelmaksoud A, et al. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an egyptian multidisciplinary clinic experience. Surg Endosc. 2014;28:3429–34.CrossRefPubMed
21.
Huang S, Yu J, Liang P, Yu X, Cheng Z, Han Z, et al. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up. Eur J Radiol. 2014;83(3):552–8.CrossRefPubMed
22.
Lin SM, Lin DY. Percutaneous local ablation therapy in small hepatocellular carcinoma. Chang Gung Med J. 2003;26(5):308–14.PubMed
23.
Simo KA, Sereika SE, Newton KN, Gerber DA. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation. J Surg Oncol. 2011;104(7):822–9.CrossRefPubMed
24.
Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol. 2009;38(3):135–43.CrossRefPubMedPubMedCentral
25.
Lencioni R, de Baere T, Martin RC, Nutting CW, Narayanan G. Image-guided ablation of malignant liver tumors: recommendations for clinical validation of novel thermal and non-thermal technologies—a western perspective. Liver Cancer. 2015;4(4):208–14.CrossRefPubMedPubMedCentral
26.
Dunne RM, Shyn PB, Sung JC, Tatli S, Morrison PR, Catalano PJ, et al. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation. Eur J Radiol. 2014;83(4):632–8.CrossRefPubMed
27.
Scheffer HJ, Melenhorst MC, Echenique AM, Nielsen K, van Tilborg AA, van den Bos W, et al. Irreversible electroporation for colorectal liver metastases. Tech Vasc Interv Radiol. 2015;18(3):159–69.CrossRefPubMed
28.
Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, et al. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;13(6):CD006317.
29.
Bala MM, Riemsma RP, Wolff R, Kleijnen J. Microwave coagulation for liver metastases. Cochrane Database of Syst Rev. 2013;10:CD010163.
30.
Mulier S, Ruers T, Jamart J, Michel L, Marchal G, Ni Y. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg. 2008;25(6):445–60.CrossRefPubMed
31.
Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.CrossRefPubMed
32.
Sietses C, Meijerink MR, Meijer S. M van den Tol MP. The impact of intraoperative ultrasonography on the surgical treatment of patients with colorectal liver metastases. Surg Endosc. 2010;24(8):1917–22.CrossRefPubMedPubMedCentral
33.
Hoch G, Croise-Laurent V, Germain A, Brunaud L, Bresler L, Ayav A. Is intraoperative ultrasound still useful for the detection of colorectal cancer liver metastases? HPB (Oxford). 2015;17(6):514–9.CrossRefPubMedPubMedCentral
34.
Knowles S, Bertens KA, Croome KP, Hernandez-Alejandro R. The current role of intraoperative ultrasound during the resection of colorectal liver metastases: a retrospective cohort study. Int J Surg. 2015;20:101–6.CrossRefPubMed
35.
D’Hondt M, Vandenbroucke-Menu F, Préville-Ratelle S, Turcotte S, Chagnon M, Plasse M, et al. Is intra-operative ultrasound still useful for the detection of a hepatic tumour in the era of modern pre-operative imaging? HPB (Oxford). 2011;13(9):665–9.CrossRefPubMedPubMedCentral
36.
Eisele RM, Neumann U, Neuhaus P, Schumacher G. Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases. World J Surg. 2009;33(4):804–11.CrossRefPubMed
37.
Burdio F, Mulier S, Navarro A, Figueras J, Berjano E, Poves I, et al. Influence of approach on outcome in radiofrequency ablation of liver tumors. Surg Oncol. 2008;17(4):295–9.CrossRefPubMed
38.
Shyn PB, Tatli S, Sahni VA, Sadow CA, Forgione K, Mauri G, et al. PET/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition. Clin Radiol. 2014;69(4):410–5.CrossRefPubMed
39.
Mauri G, Cova L, De Beni S, Ierace T, Tondolo T, Cerri A, et al. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38(1):143–51.CrossRefPubMed
40.
van Tilborg AA, Scheffer HJ, Nielsen K, van Waesberghe JH, Comans EF, van Kuijk C, et al. Transcatheter CT arterial portography and CT hepatic arteriography for liver tumor visualization during percutaneous ablation. J Vasc Interv Radiol. 2014;25(7):1101–11.CrossRefPubMed
41.
Nielsen K, van Tilborg AA, Scheffer HJ, Meijerink MR, de Lange-de Klerk ES, Meijer S, et al. PET-CT after radiofrequency ablation of colorectal liver metastases: suggestions for timing and image interpretation. Eur J Radiol. 2013;82(12):2169–75.CrossRefPubMed
Metadata
Title
MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts
Authors
Aukje A. J. M. van Tilborg
Hester J. Scheffer
Marcus C. de Jong
Laurien G. P. H. Vroomen
Karin Nielsen
Cornelis van Kuijk
Petrousjka M. P. van den Tol
Martijn R. Meijerink
Publication date
01-10-2016
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 10/2016
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-016-1413-3

Other articles of this Issue 10/2016

CardioVascular and Interventional Radiology 10/2016 Go to the issue

Letter to the Editor

Letter to Editor

Clinical Investigation

Minilaparotomy-Assisted Transmesenteric-Transjugular Intrahepatic Portosystemic Shunt: Comparison with Conventional Transjugular Approach

Case Report

Uncommon Case of a Post-Traumatic Portal Vein Pseudoaneurysm Treated with Percutaneous Transhepatic Stent Grafting

Clinical Investigation

Treatment Outcome Following Transarterial Chemoembolization in Advanced Bone and Soft Tissue Sarcomas

Clinical Investigation

Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma

Erratum

Erratum to: Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma